溶酶体在癌症发育和进展中的双重作用
Xiao-Qiong Chen1, Quan Yang1, Wei-Min Chen1
1Colorectal Surgery, Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan, 650000 Kunming, Yunnan, China.
Frontiers in bioscience (Landmark edition)
|November 30, 2024
概括
溶解体是参与细胞循环的重要器官. 它们的功能障碍与衰老和癌症有关,但它们在癌症中的作用是复杂的,具有抑制和促进作用.
科学领域:
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 溶解体是细胞循环和恒温的关键催化器官,对于细胞循环和恒温是必不可少的.
- 溶酶体功能障碍与衰老和与年龄相关的疾病,包括癌症有关.
- 自-溶酶体通路在细胞过程中发挥关键作用,如自调节,离子稳态,细胞死亡和衰老.
研究的目的:
- 审查溶解体和细胞功能中的自-溶解体通路的基本作用.
- 突出自-溶酶体途径在癌症发展和进展中的双重作用.
- 为了强调针对癌症治疗的自-溶酶体途径的潜力.
主要方法:
- 对溶解体和自-溶解体通路研究的文献综述.
- 分析这些途径在衰老和癌症中的参与.
- 综合了关于不同癌症中 lysosomal 途径上下文依赖功能的信息.
主要成果:
- 溶解体对于降解受损的细胞组件和回收分子至关重要.
- 溶酶体功能障碍与衰老和各种疾病有关,尤其是癌症.
- 自-溶酶体通路表现出取决于环境的癌症抑制和癌症促进功能,使其治疗应用复杂化.
结论:
- 自-溶酶体通路是细胞健康和疾病的组成部分,特别是在癌症中.
- 了解这种途径的双重作用对于开发有效的癌症疗法至关重要.
- 准自-溶酶体通路对新型癌症治疗策略具有前景.
更多相关视频
10:25Dual-color Correlative Light and Electron Microscopy for the Visualization of Interactions between Mitochondria and Lysosomes
Published on: September 27, 2024
536
08:11Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
Published on: March 26, 2018
8.3K
相关概念视频
Delivery Pathways to the Lysosome
6.2K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.2K
Lysosomes
16.4K
Lysosomes are membrane-enclosed spherical sacs derived from the Golgi apparatus. The most important function of the lysosome is degrading macromolecules and biological polymers that are released during membrane trafficking events such as the secretory, endocytic, autophagic, and phagocytic pathways. The degradation is carried out by several hydrolytic enzymes active in an acidic environment of the lysosomal lumen. These acid hydrolases are involved in cellular processes such as cell signaling,...
16.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
